FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Schmaljohn

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Disorders

Anatomy

Vero Cells

Co-author Network

Publications

TOP 3
Loreen L Lofts; M Sofi Ibrahim; diane negley; Michael Hevey; Alan L Schmaljohn
Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.
Mansour Mohamadzadeh; Lieping Chen; Alan L Schmaljohn
How Ebola and Marburg viruses battle the immune system.
John S Lee; Jennifer L Groebner; Angela G Hadjipanayis; diane negley; Alan L Schmaljohn; Susan L Welkos; Leonard A Smith; Jonathan F Smith
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Schmaljohn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Loreen L Lofts; M Sofi Ibrahim; diane negley; Michael Hevey; Alan L Schmaljohn
Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.
The Journal of infectious diseases 2007;196 Suppl 2():S305-12.
2007: Mansour Mohamadzadeh; Lieping Chen; Alan L Schmaljohn
How Ebola and Marburg viruses battle the immune system.
Nature reviews. Immunology 2007;7(7):556-67.
2006: John S Lee; Jennifer L Groebner; Angela G Hadjipanayis; diane negley; Alan L Schmaljohn; Susan L Welkos; Leonard A Smith; Jonathan F Smith
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
Vaccine 2006;24(47-48):6886-92.
2006: Mansour Mohamadzadeh; Sadie S Coberley; Gene Garrard Olinger; Warren V Kalina; Gordon Ruthel; Claudette L Fuller; Dana L Swenson; William D Pratt; Douglas B Kuhns; Alan L Schmaljohn
Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
Journal of virology 2006;80(14):7235-44.
2006: Danher Wang; Alan L Schmaljohn; Nicholas U Raja; Charles M Trubey; Laure Y Juompan; Min Luo; Stephen B Deitz; Hong Yu; Jan Woraratanadharm; David H Holman; Kevin M Moore; Benjamin M Swain; William D Pratt; Jian-Yun Dong
De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
Vaccine 2006;24(15):2975-86.
2006: Mansour Mohamadzadeh; Lieping Chen; Gene Garrard Olinger; William D Pratt; Alan L Schmaljohn
Filoviruses and the balance of innate, adaptive, and inflammatory responses.
Viral immunology 2006;19(4):602-12.
2005: Dana L Swenson; Kelly L Warfield; diane negley; Alan L Schmaljohn; M Javad Aman; Sina Bavari
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Vaccine 2005;23(23):3033-42.
2005: James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
The evolving field of biodefence: therapeutic developments and diagnostics.
Nature reviews. Drug discovery 2005;4(4):281-97.
2004: Kelly L Warfield; Dana L Swenson; diane negley; Alan L Schmaljohn; M Javad Aman; Sina Bavari
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
Vaccine 2004;22(25-26):3495-502.
2004: Jay W Hooper; E Thompson; C Wilhelmsen; M Zimmerman; M Ait Ichou; S E Steffen; Connie S Schmaljohn; Alan L Schmaljohn; Peter B Jahrling
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
Journal of virology 2004;78(9):4433-43.
2004: Dana L Swenson; Kelly L Warfield; Kathleen Kuehl; Thomas Larsen; Michael Hevey; Alan L Schmaljohn; Sina Bavari; M Javad Aman
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.
FEMS immunology and medical microbiology 2004;40(1):27-31.
2003: Kelly L Warfield; Catharine M Bosio; Brent C Welcher; Emily M Deal; Mansour Mohamadzadeh; Alan L Schmaljohn; M Javad Aman; Sina Bavari
Ebola virus-like particles protect from lethal Ebola virus infection.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15889-94.
2003: Catharine M Bosio; M Javad Aman; Case Grogan; Robert Jeffrey Hogan; Gordon Ruthel; diane negley; Mansour Mohamadzadeh; Sina Bavari; Alan L Schmaljohn
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.
The Journal of infectious diseases 2003;188(11):1630-8.
2003: Michael Hevey; diane negley; Alan L Schmaljohn
Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes.
Virology 2003;314(1):350-7.
2003: Jenny Riemenschneider; Aura Garrison; Joan B Geisbert; Peter B Jahrling; Michael Hevey; diane negley; Alan L Schmaljohn; John Lee; Mary Kate Hart; Lorna VanderZanden; David M Custer; Mike Bray; Albert Ruff; Bruce Ivins; Anthony Bassett; Cynthia Rossi; Connie S Schmaljohn
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.
Vaccine 2003;21(25-26):4071-80.
2003: M Sofi Ibrahim; David A Kulesh; Sharron S Saleh; Inger K Damon; Joseph J Esposito; Alan L Schmaljohn; Peter B Jahrling
Real-time PCR assay to detect smallpox virus.
Journal of clinical microbiology 2003;41(8):3835-9.
2003: M Javad Aman; Catharine M Bosio; Rekha G Panchal; James C Burnett; Alan L Schmaljohn; Sina Bavari
Molecular mechanisms of filovirus cellular trafficking.
Microbes and infection / Institut Pasteur 2003;5(7):639-49.
2002: Luciana Borio; Thomas V Inglesby; Clarence Peters; Alan L Schmaljohn; James Hughes; Peter B Jahrling; Thomas Ksiazek; Karl M Johnson; Andrea Nikki Meyerhoff; Tara O'Toole; Michael S Ascher; John G Bartlett; Joel G Breman; Edward M Eitzen; Margaret Hamburg; Jerry Hauer; Donald A Henderson; Richard T Johnson; Gigi Kwik; Marcelle Layton; Scott R Lillibridge; Gary Nabel; Michael Osterholm; Trish M Perl; Philip Russell; Kevin Tonat
Hemorrhagic fever viruses as biological weapons: medical and public health management.
JAMA : the journal of the American Medical Association 2002;287(18):2391-405.
2002: Sina Bavari; Catharine M Bosio; Elizabeth Wiegand; Gordon Ruthel; Amy B Will; Thomas W Geisbert; Michael Hevey; Connie S Schmaljohn; Alan L Schmaljohn; M Javad Aman
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.
The Journal of experimental medicine 2002;195(5):593-602.
2001: Michael Hevey; diane negley; Lorna VanderZanden; RF Tammariello; Joan B Geisbert; Connie S Schmaljohn; Jonathan F Smith; Peter B Jahrling; Alan L Schmaljohn
Marburg virus vaccines: comparing classical and new approaches.
Vaccine 2001;20(3-4):586-93.
2001: SY Chan; Cyril J. Empig; Frank Welte; Roberto F Speck; Alan L Schmaljohn; Jason F Kreisberg; Mark A Goldsmith
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.
Cell 2001;106(1):117-26.
2000: Peter Pushko; Mike Bray; George V Ludwig; M Parker; Alan L Schmaljohn; A Sanchez; Peter B Jahrling; Jonathan F Smith
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Vaccine 2000;19(1):142-53.
2000: JA Wilson; Michael Hevey; Russell Bakken; S Guest; Mike Bray; Alan L Schmaljohn; Mary Kate Hart
Epitopes involved in antibody-mediated protection from Ebola virus.
Science (New York, N.Y.) 2000;287(5458):1664-6.
2000: Jay W Hooper; David M Custer; Connie S Schmaljohn; Alan L Schmaljohn
DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
Virology 2000;266(2):329-39.
2000: DJ McClain; P L Summers; S A Harrison; Alan L Schmaljohn; Connie S Schmaljohn
Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine.
Journal of medical virology 2000;60(1):77-85.
1999: Marion Subklewe; A Chahroudi; Alan L Schmaljohn; Michael Kurilla; Nina Bhardwaj; Ralph M Steinman
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus.
Blood 1999;94(4):1372-81.
1998: Michael Hevey; diane negley; Peter Pushko; J Smith; Alan L Schmaljohn
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
Virology 1998;251(1):28-37.
1998: Lorna VanderZanden; Mike Bray; D Fuller; T Roberts; David M Custer; Kristin Spik; Peter B Jahrling; John W Huggins; Alan L Schmaljohn; Connie S Schmaljohn
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
Virology 1998;246(1):134-44.
1998: William D Pratt; P Gibbs; M L Pitt; Alan L Schmaljohn
Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Vaccine 1998;16(9-10):1056-64.
1998: DJ McClain; Phillip R Pittman; H H Ramsburg; G O Nelson; Cynthia A Rossi; Joseph A Mangiafico; Alan L Schmaljohn; Frank J Malinoski
Immunologic interference from sequential administration of live attenuated alphavirus vaccines.
The Journal of infectious diseases 1998;177(3):634-41.
1998: A Nardin; William M Sutherland; Michael Hevey; Alan L Schmaljohn; Ronald P Taylor
Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes.
Journal of immunological methods 1998;211(1-2):21-31.
1997: Michael Hevey; diane negley; Joan B Geisbert; Peter B Jahrling; Alan L Schmaljohn
Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.
Virology 1997;239(1):206-16.
1995: Y K Chu; G Jennings; Alan L Schmaljohn; Fredrik Elgh; Brian Hjelle; H W Lee; S Jenison; T Ksiazek; Clarence Peters; P Rollin
Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients.
The Journal of infectious diseases 1995;172(6):1581-4.
1995: D Li; Alan L Schmaljohn; K Anderson; Connie S Schmaljohn
Complete nucleotide sequences of the M and S segments of two hantavirus isolates from California: evidence for reassortment in nature among viruses related to hantavirus pulmonary syndrome.
Virology 1995;206(2):973-83.
1995: Alan L Schmaljohn; D Li; diane negley; D S Bressler; Michael Turell; George W Korch; M S Ascher; Connie S Schmaljohn
Isolation and initial characterization of a newfound hantavirus from California.
Virology 1995;206(2):963-72.
1994: James H Strauss; K S Wang; Alan L Schmaljohn; Richard J Kuhn; Ellen G Strauss
Host-cell receptors for Sindbis virus.
Archives of virology. Supplementum 1994;9():473-84.
1992: S D London; Alan L Schmaljohn; J M Dalrymple; Charles M Rice
Infectious enveloped RNA virus antigenic chimeras.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):207-11.
1991: Ellen G Strauss; D S Stec; Alan L Schmaljohn; James H Strauss
Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants.
Journal of virology 1991;65(9):4654-64.
1991: K S Wang; Alan L Schmaljohn; Richard J Kuhn; James H Strauss
Antiidiotypic antibodies as probes for the Sindbis virus receptor.
Virology 1991;181(2):694-702.
1990: Connie S Schmaljohn; Y K Chu; Alan L Schmaljohn; J M Dalrymple
Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.
Journal of virology 1990;64(7):3162-70.
1989: Connie S Schmaljohn; M D Parker; W H Ennis; J M Dalrymple; Marc S Collett; JoAnn A Suzich; Alan L Schmaljohn
Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.
Virology 1989;170(1):184-92.
1989: J Arikawa; Alan L Schmaljohn; J M Dalrymple; Connie S Schmaljohn
Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies.
The Journal of general virology 1989;70 ( Pt 3)():615-24.
1988: Connie S Schmaljohn; K Sugiyama; Alan L Schmaljohn; D H Bishop
Baculovirus expression of the small genome segment of Hantaan virus and potential use of the expressed nucleocapsid protein as a diagnostic antigen.
The Journal of general virology 1988;69 ( Pt 4)():777-86.
1987: Nancy L Davis; D F Pence; W J Meyer; Alan L Schmaljohn; Robert E Johnston
Alternative forms of a strain-specific neutralizing antigenic site on the Sindbis virus E2 glycoprotein.
Virology 1987;161(1):101-8.
1987: Connie S Schmaljohn; Alan L Schmaljohn; J M Dalrymple
Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order.
Virology 1987;157(1):31-9.
1986: D S Stec; A Waddell; Connie S Schmaljohn; G A Cole; Alan L Schmaljohn
Antibody-selected variation and reversion in Sindbis virus neutralization epitopes.
Journal of virology 1986;57(3):715-20.
1983: Alan L Schmaljohn; K M Kokubun; G A Cole
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.
Virology 1983;130(1):144-54.
1982: Alan L Schmaljohn; E D Johnson; J M Dalrymple; G A Cole
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis.
Nature 1982;297(5861):70-2.